Marquez, Paige L.

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

Shimabukuro, T. T., Kim, S. Y., Myers, T. R., Moro, P. L., Oduyebo, T., Panagiotakopoulos, L., Marquez, P. L., Olson, C. K., Liu, R., Chang, K. T., et al. (2021) · New England Journal of Medicine

COVID-19 Impact on ReproductionSARS-CoV-2 and COVID-19 Research

Cited by 927

First Month of COVID-19 Vaccine Safety Monitoring — United States, December 14, 2020–January 13, 2021

Gee, J., Marquez, P., Su, J., Calvert, G. M., Liu, R., Myers, T., Nair, N., Martin, S., Clark, T., Markowitz, L., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report

SARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 395

Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system

Chapin-Bardales, J., Myers, T., Gee, J., Shay, D. K., Marquez, P., Baggs, J., Zhang, B., Licata, C., & Shimabukuro, T. T. (2021) · Vaccine

SARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 23

Is there any harm in administering extra-doses of vaccine to a person? Excess doses of vaccine reported to the Vaccine Adverse Event Reporting System (VAERS), 2007–2017.

Moro, P. L., Arana, J., Marquez, P. L., Ng, C., Barash, F., Hibbs, B. F., & Cano, M. (2019) · Vaccine

Pharmacovigilance and Adverse Drug ReactionsPatient Safety and Medication Errors

Cited by 17